Anti-metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes
- PMID: 39396919
- DOI: 10.1111/cbdd.14637
Anti-metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes
Abstract
Apitherapy has started to gain tremendous recognition because of extraordinary pharmacological importance of honeybee-related ingredients and their derivatives. There has been a renewed interest in the bee venom-based therapies. Interdisciplinary researchers are studying the chemistry and translational value of venom for effective cancer treatment. Bee venom and its major component, melittin, are cytotoxic in cancer cells. In this study, MTT and scratch assays were performed for analysis of melittin-mediated antimetastatic effects. QPCR was used for expression profiling of metastasis-related genes. Three anti-metastatic genes (BRMS1, DRG1, and KAI1/CD82) were studied for the first time after bee venom and melittin treatment in MDA-MB-231 breast cancer cells compared with normal breast cells, and two prometastatic genes (EGFR and WNT7B) were also examined. KAI1/CD82 and BRMS1 are the negative regulators of EGFR. WNT7B is a negative regulator of KAI1/CD82. Selective cytotoxicity of bee venom and melittin was found to be higher as compared to cisplatin. Melittin induced an increase in the expression of BRMS1 and DRG1, whereas bee venom upregulated DRG1 and KAI1/CD82 expression in breast cancer. WNT7B was downregulated in bee venom-treated breast cancer cells. Results suggested that bee venom/melittin exerted antimetastatic effects primarily through upregulation of BRMS1, DRG1, and KAI1/CD82, and downregulation of WNT7B.
Keywords: bee venom; breast cancer; melittin; metastasis; scratch assay.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms.J Ethnopharmacol. 2010 Feb 17;127(3):662-8. doi: 10.1016/j.jep.2009.12.007. Epub 2009 Dec 5. J Ethnopharmacol. 2010. PMID: 19969058
-
Bee Venom Components as Therapeutic Tools against Prostate Cancer.Toxins (Basel). 2021 May 7;13(5):337. doi: 10.3390/toxins13050337. Toxins (Basel). 2021. PMID: 34067049 Free PMC article. Review.
-
Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway.Toxicol Appl Pharmacol. 2012 Jan 1;258(1):72-81. doi: 10.1016/j.taap.2011.10.009. Epub 2011 Oct 15. Toxicol Appl Pharmacol. 2012. PMID: 22027265
-
Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB.Prostate. 2011 Jun 1;71(8):801-12. doi: 10.1002/pros.21296. Epub 2010 Nov 17. Prostate. 2011. PMID: 21456063
-
An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers.Nutrients. 2023 Jul 12;15(14):3111. doi: 10.3390/nu15143111. Nutrients. 2023. PMID: 37513529 Free PMC article. Review.
Cited by
-
Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer.Theranostics. 2025 May 8;15(13):6111-6145. doi: 10.7150/thno.113356. eCollection 2025. Theranostics. 2025. PMID: 40521202 Free PMC article. Review.
References
-
- Abdulmalek, S., N. Mostafa, M. Gomaa, M. El‐Kersh, A. I. Elkady, and M. Balbaa. 2022. “Bee Venom‐Loaded EGFR‐Targeting Peptide‐Coupled Chitosan Nanoparticles for Effective Therapy of Hepatocellular Carcinoma by Inhibiting EGFR‐Mediated MEK/ERK Pathway.” PLoS One 17, no. 8: e0272776. https://doi.org/10.1371/JOURNAL.PONE.0272776.
-
- Ayazoglu Demir, E., A. Colak, S. C. Uzuner, and O. Bekircan. 2021. “Cytotoxic Effect of a 3‐(4‐Chlorophenyl)‐5‐(4‐Methoxybenzyl)‐4H‐1,2,4‐Triazole Derivative Compound in Human Melanoma Cells.” International Journal of Biology and Chemistry 14, no. 1: 139–148. https://doi.org/10.26577/IJBCH.2021.V14.I1.015.
-
- Badawi, J. K. 2021. “Bee Venom Components as Therapeutic Tools Against Prostate Cancer.” Toxins 13, no. 5: 337. https://doi.org/10.3390/toxins13050337.
-
- Baig, R. M., A. J. Sanders, M. A. Kayani, and W. G. Jiang. 2012. “Association of Differentiation‐Related Gene‐1 (DRG1) With Breast Cancer Survival and In Vitro Impact of DRG1 Suppression.” Cancers 4, no. 3: 658–672. https://doi.org/10.3390/cancers4030658.
-
- Çelik Uzuner, S., E. Birinci, S. Tetikoğlu, C. Birinci, and S. Kolaylı. 2021. “Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity After Bee Venom Treatment.” Recent Patents on Anti‐Cancer Drug Discovery 16, no. 3: 377–392. https://doi.org/10.2174/1574892816666210422125058.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous